Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong · Delayed Price · Currency is HKD 1.020
-0.020 (-1.92%)
Aug 21, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Market Cap
Venus Medtech (Hangzhou) has a market cap or net worth of 446.66 million as of August 21, 2026. Its market cap has decreased by -77.89% in one year.
Market Cap
446.66M
Enterprise Value
393.88M
Revenue
341.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.02
ChartMarket Cap Chart
Since December 10, 2019, Venus Medtech (Hangzhou)'s market cap has decreased from 16.91B to 446.66M, a decrease of -97.36%. That is a compound annual growth rate of -41.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 446.66M | -57.14% |
| Dec 31, 2025 | 1.04B | -83.31% |
| Dec 30, 2022 | 6.24B | -51.82% |
| Dec 31, 2021 | 12.96B | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai HeartCare Medical Technology Corporation | 1.87B |
| MicroPort CardioFlow Medtech | 1.62B |
| Sisram Medical | 1.01B |
| Cryofocus Medtech (Shanghai) | 860.14M |
| Gaush Meditech | 662.18M |
| Vincent Medical Holdings | 468.30M |
| Suzhou Basecare Medical Corporation | 384.30M |
| Austar Lifesciences | 358.81M |